Cargando…
Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failure
BACKGROUND: Therapeutic drug monitoring of mycophenolic acid (MPA) is usually performed with a limited sampling strategy (LSS), which relies on a limited number of blood samples and subsequent extrapolation of the global exposure to MPA. LSS is usually performed successfully with mycophenolate mofet...
Autores principales: | Hougardy, Jean-Michel, Maufort, Laurette, Cotton, Frédéric, Coussement, Julien, Mikhalski, Dimitri, Wissing, Karl M., Le Moine, Alain, Broeders, Nilufer, Abramowicz, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792630/ https://www.ncbi.nlm.nih.gov/pubmed/26985386 http://dx.doi.org/10.1093/ckj/sfw001 |
Ejemplares similares
-
Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effects
por: Abramowicz, Daniel, et al.
Publicado: (2008) -
Celiac-like Enteropathy Associated With Mycophenolate Sodium in Renal Transplant Recipients
por: Filiopoulos, Vassilis, et al.
Publicado: (2018) -
Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN)
por: Ranganathan, Dwarakanathan, et al.
Publicado: (2019) -
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
por: Gardiner, Kyle M., et al.
Publicado: (2018) -
Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease
por: Jones, Rachel B., et al.
Publicado: (2014)